VBI Vaccines Inc/BC Common Stock, Value, Issued
VBI Vaccines Inc/BC had Common Stock, Value, Issued of $455.06 million as of 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2024-05-15
- 2024-03-31: Common Stock, Value, Issued $455.06M.
- 2023-12-31: Common Stock, Value, Issued $454.21M.
- 2023-09-30: Common Stock, Value, Issued $453.90M.
- 2023-06-30: Common Stock, Value, Issued $442.32M.
| Period end | Common Stock, Value, Issued |
|---|---|
| 2024-03-31 | $455.06M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $454.21M 10-Q · filed 2024-05-15 |
| 2023-09-30 | $453.90M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $442.32M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $442.32M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $442.31M 10-K · filed 2024-04-16 |
| 2022-09-30 | $442.30M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $442.29M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $442.27M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $442.24M 10-K · filed 2023-03-13 |
| 2021-09-30 | $439.29M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $432.27M 10-Q · filed 2021-08-02 |
| 2021-03-31 | $427.05M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $403.53M 10-K · filed 2022-03-07 |
| 2020-09-30 | $387.72M 10-Q · filed 2020-11-02 |
| 2020-06-30 | $338.63M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $285.10M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $284.96M 10-K · filed 2021-03-02 |
| 2019-09-30 | $284.89M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $247.28M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $246.85M 10-Q · filed 2019-05-01 |
| 2018-12-31 | $246.42M 10-K · filed 2020-03-05 |
| 2018-09-30 | $202.96M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $202.57M 10-Q · filed 2018-07-26 |
| 2018-03-31 | $201.90M 10-Q · filed 2018-05-01 |
| 2017-12-31 | $201.81M 10-K · filed 2019-02-25 |
| 2017-09-30 | $134.05M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $134.04M 10-Q · filed 2017-07-31 |
| 2017-03-31 | $133.41M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $133.31M 10-K · filed 2018-02-26 |
| 2015-12-31 | $44.37M 10-K · filed 2017-03-20 |